Evolutionary design of optimal surface topographies for biomaterials.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
17 12 2020
Historique:
received: 04 10 2020
accepted: 30 11 2020
entrez: 18 12 2020
pubmed: 19 12 2020
medline: 19 12 2020
Statut: epublish

Résumé

Natural evolution tackles optimization by producing many genetic variants and exposing these variants to selective pressure, resulting in the survival of the fittest. We use high throughput screening of large libraries of materials with differing surface topographies to probe the interactions of implantable device coatings with cells and tissues. However, the vast size of possible parameter design space precludes a brute force approach to screening all topographical possibilities. Here, we took inspiration from Nature to optimize materials surface topographies using evolutionary algorithms. We show that successive cycles of material design, production, fitness assessment, selection, and mutation results in optimization of biomaterials designs. Starting from a small selection of topographically designed surfaces that upregulate expression of an osteogenic marker, we used genetic crossover and random mutagenesis to generate new generations of topographies.

Identifiants

pubmed: 33335124
doi: 10.1038/s41598-020-78777-2
pii: 10.1038/s41598-020-78777-2
pmc: PMC7746696
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

22160

Références

J Invest Surg. 2017 Feb;30(1):56-65
pubmed: 27537783
Sci Adv. 2016 Oct 07;2(10):e1600567
pubmed: 27730209
Sci Adv. 2016 Oct 14;2(10):e1600909
pubmed: 27757420
Nat Biotechnol. 2012 Sep;30(9):868-875
pubmed: 22885723
Adv Mater. 2013 Feb 13;25(6):802-24
pubmed: 23297023
Sci Rep. 2016 Jan 13;6:18948
pubmed: 26757610
Adv Drug Deliv Rev. 2013 Apr;65(4):581-603
pubmed: 22820527
Trends Biotechnol. 2017 Aug;35(8):743-755
pubmed: 28693857
Chem Rev. 2012 May 9;112(5):2889-919
pubmed: 22251444
Toxicol Pathol. 2008 Jan;36(1):85-91
pubmed: 18337225
Biomaterials. 2017 Aug;137:49-60
pubmed: 28535442
Nat Methods. 2011 Oct 09;8(11):949-55
pubmed: 21983923
J Cogn Neurosci. 1991 Winter;3(1):71-86
pubmed: 23964806
Proc Natl Acad Sci U S A. 2011 Oct 4;108(40):16565-70
pubmed: 21949368
ChemMedChem. 2015 Aug;10(8):1296-300
pubmed: 26059362
Acta Biomater. 2009 May;5(4):945-58
pubmed: 19111513
J Mech Behav Biomed Mater. 2016 Jan;53:350-365
pubmed: 26398780
Chem Rev. 2016 May 25;116(10):6107-32
pubmed: 27171499
Nature. 2015 May 28;521(7553):476-82
pubmed: 26017447
MRS Bull. 2013 Feb;38(2):169-176
pubmed: 24163499
Science. 1993 Aug 13;261(5123):872-8
pubmed: 8346439
Adv Healthc Mater. 2016 Oct;5(20):2575-2594
pubmed: 27593734
Sci Adv. 2016 Nov 23;2(11):e1600954
pubmed: 28138523

Auteurs

Aliaksei Vasilevich (A)

Institute for Complex Molecular Systems and Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands.

Aurélie Carlier (A)

MERLN Institute for Technology-Inspired Regenerative Medicine, Department of Cell Biology-Inspired Tissue Engineering, Maastricht University, Maastricht, The Netherlands.

David A Winkler (DA)

Materials Science & Engineering, Commonwealth Scientific and Industrial Research Organisation, Clayton, VIC, Australia.
Monash Institute of Pharmaceutical Sciences, Monash Univeristy, Parkville, VIC, Australia.
Latrobe Institute for Molecular Science, La Trobe University, Melbourne, VIC, Australia.
School of Pharmacy, University of Nottingham, Nottingham Park, UK.

Shantanu Singh (S)

Imaging Platform, Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Jan de Boer (J)

Institute for Complex Molecular Systems and Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands. j.d.boer@tue.nl.

Classifications MeSH